Skip to content

Metabolic Response to Fat and Glucose

Metabolic Response to Fat and Glucose

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02603237
Enrollment
60
Registered
2015-11-11
Start date
2016-07-31
Completion date
2020-06-30
Last updated
2023-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Insulin Resistance, Healthy

Brief summary

The study will compare plasma and urine post-prandial metabolomics after fat and glucose oral load according to lifestyle factors.

Detailed description

The metabolic response in plasma and urine, pre- and post-load tests in people with specific dietary lifestyles will be tested. This project will focus on fat and glucose induced changes of targeted metabolic pathways that have been related to diabetes and obesity risk.

Interventions

Standardized oral glucose tolerance test (75 g oral glucose) and blood collection before and 2hrs after the glucose load

OTHERFat tolerance test

Oral fat tolerance will be provided to fasting participants and blood samples will be collected before and 4 hrs after the fat load.

Sponsors

Universität des Saarlandes
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteers * On a stable dietary habits

Exclusion criteria

* Pregnancy * Malabsorption disorders * Present or former cancer * Any oral medication that affect glucose or fat absorptions * Cholesterol lowering drugs (i.e. Statins) * other drugs: fibrates, MTX, or vitamin supplements * Diabetes (type 1 and type 2) * Alcoholism * Weight losing diet during the last 4 months * Liver diseases * Renal dysfunction * Gastric resection.

Design outcomes

Primary

MeasureTime frame
Plasma levels of branched chain amino acidChanges between baseline and 2 hours
Plasma Trimethylamin N-oxideChanges between baseline and 2 hours
Plasma glucose levelChanges between baseline and 2 hours
Plasma glucoseChanges between baseline and 2 hours
Plasma level of acetyl-CoAChanges between baseline and 2 hours

Secondary

MeasureTime frame
Plasma malonyl-CoAChanges between baseline and 2 hours
Plasma pyruvateChanges between baseline and 2 hours
Plasma phosphatidylcholineChanges between baseline and 2 hours
Plasma insulinChanges between baseline and 2 hours
Plasma leptinChanges between baseline and 2 hours
Plasma LactateChanges between baseline and 2 hours

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026